Search results for "FIBRILLATION"

showing 10 items of 509 documents

Noninvasive peripheral vascular function and atrial fibrillation in the general population.

2019

Background Arterial stiffness is a strong predictor of atrial fibrillation in the community. Whether noninvasively measured conduit artery function and peripheral vascular reactivity are related to atrial fibrillation remains unknown. Methods and results In 15 010 individuals of the population-based Gutenberg Health Study, mean age 55 ± 11 years, 50.5% men, we determined noninvasive vascular function by flow-mediated dilation (FMD) and peripheral arterial tonometry (PAT) in relation to manifest atrial fibrillation (N = 466). Patients with atrial fibrillation exhibited a higher mean brachial artery diameter [4.81 mm (4.17, 5.33) in atrial fibrillation vs. 4.31 mm (3.67, 4.93)] and baseline p…

AdultMalemedicine.medical_specialtyBrachial ArteryPhysiologyManometryArbitrary unitPopulation030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineVascular StiffnessRisk FactorsInternal medicinemedicine.arteryAtrial FibrillationInternal MedicinemedicineHumanscardiovascular diseases030212 general & internal medicineBrachial arteryeducationAgededucation.field_of_studybusiness.industryAtrial fibrillationOdds ratioMiddle Agedmedicine.diseaseConfidence intervalVasodilationmedicine.anatomical_structurecardiovascular systemCardiologyArterial stiffnessFemaleCardiology and Cardiovascular MedicinebusinessArteryJournal of hypertension
researchProduct

Competitive interaction between chronic obstructive pulmonary disease and CHA2DS2-VASc score in predicting incident atrial fibrillation

2018

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, and an emerging risk factor for atrial fibrillation (AF). CHADS2 and CHA2DS2-VASc scores are significantly associated with incident AF independently of other risk factors. The aim of this study was to demonstrate a possible interaction between COPD and CHA2DS2-VASc in predicting incident AF. Methods: This observational prospective cohort study included 4322 Caucasians with cardiovascular risk factors, stratified by CHA2DS2-VASc score (> 2 vs < 2) and presence/absence of COPD. To detect AF appearance, patients underwent, every 6 months, physical examination, standard 12‑lead electrocardiog…

AdultMalemedicine.medical_specialtyCHA2DS2-VASc scorePulmonary diseasePredictive Value of Test030204 cardiovascular system & hematologySeverity of Illness IndexFollow-Up Studie03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicinemedicineCompetitive interaction030212 general & internal medicineProspective cohort studyAgedCOPDbusiness.industryProportional hazards modelIncidence (epidemiology)Chronic obstructive pulmonary diseaseIncidenceAtrial fibrillationMiddle Agedmedicine.diseaseCardiovascular riskAtrial fibrillationProspective Studieatrial fibrillation; cha(2)ds(2)-vasc score; cardiovascular risk; chronic obstructive pulmonary diseaseCHA2DS2–VASc scoreCardiologyFemaleCohort StudiebusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Refined atrial fibrillation screening and cost-effectiveness in the German population

2021

ObjectiveLittle is known on optimal screening population for detecting new atrial fibrillation (AF) in the community. We describe characteristics and estimate cost-effectiveness for a single timepoint electrocardiographic screening.MethodsWe performed a 12-lead ECG in the German population-based Gutenberg Health Study between 2007 and 2012 (n=15 010), mean age 55±11 years, 51% men and collected more than 120 clinical and biomarker variables, including N-terminal pro B-type natriuretic peptide (Nt-proBNP), risk factors, disease symptoms and echocardiographic variables.ResultsOf 15 010 individuals, 466 (3.1%) had AF. New AF was found in 32 individuals, 0.2% of the total sample, 0.5% of indivi…

AdultMalemedicine.medical_specialtyCost effectivenessCost-Benefit AnalysisPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineAtrial FibrillationNatriuretic Peptide BrainEpidemiologyHumansMedicine030212 general & internal medicineRisk factoreducationStrokeAgedHeart Failureeducation.field_of_studybusiness.industryAtrial fibrillationMiddle Agedmedicine.diseasePeptide Fragments3. Good healthStrokeHeart failureBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersHeart
researchProduct

Atrial Fibrillation Manifestations Risk Factors and Sex Differences in a Population-Based Cohort (From the Gutenberg Health Study)

2018

Sex differences in cardiovascular risk factors, cardiac structure and function, and disease and symptom burden in the common arrhythmia atrial fibrillation (AF) have not been investigated systematically at the population level. Cross-sectional data of 14,796 subjects (age range 35 to 74 years, 50.5% men) from the population-based Gutenberg Health Study were examined to show the distribution of cardiovascular risk factors by AF status and sex, and to determine sex-specific predictors for AF. The prevalence of AF was higher in men (4.3%) than in women (1.9%). Men had a worse cardiovascular risk factor profile, a higher prevalence of cardiovascular disease, but fewer symptoms than women. Age-a…

AdultMalemedicine.medical_specialtyCross-sectional studyHeart VentriclesPopulation030204 cardiovascular system & hematologyRisk AssessmentVentricular Function LeftCoronary artery diseaseElectrocardiography03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationPrevalenceHumansMedicine030212 general & internal medicineMyocardial infarctionRisk factoreducationAgedRetrospective Studieseducation.field_of_studybusiness.industryIncidenceRetrospective cohort studyAtrial fibrillationOdds ratioMiddle Agedmedicine.disease3. Good healthSurvival RateCross-Sectional StudiesEchocardiographyPopulation SurveillanceCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: resu…

1999

Whether the safety and efficacy of implantable cardioverter defibrillator (ICD) therapy can be assured with lower output devices is an important question. The purpose of this study was to evaluate whether programming the device output at twice the augmented defibrillation threshold was as safe and effective as using the maximum energy. Patients indicated for ICD therapy, but without slow monomorphic ventricular tachycardia (MVT), who achieved an augmented defibrillation threshold (DFT plus)or = 15 joules (J) with a single endocardial lead system and a biphasic defibrillator were included in the study. Prior to ICD implantation, patients were randomized into 2 groups. The shock energies in t…

AdultMalemedicine.medical_specialtyDefibrillationTest groupmedicine.medical_treatmentImplantable defibrillatorDefibrillation thresholdElectrocardiographyLow energyInternal medicineMedicineHumansProspective StudiesAgedEjection fractionEquipment Safetybusiness.industryMiddle AgedImplantable cardioverter-defibrillatorDefibrillators ImplantableSurvival RateTreatment OutcomeShock (circulatory)Ventricular FibrillationCardiologyTachycardia VentricularFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessSoftwareThe American journal of cardiology
researchProduct

Gabor frames for classification of paroxysmal and persistent atrial fibrillation episodes

2016

[EN] In this study, we propose a new classification method for early differentiation of paroxysmal and persistent atrial fibrillation episodes, i.e. those which spontaneously or with external intervention will return to sinus rhythm within 7 days of onset from the ones where the arrhythmia is sustained for more than 7 days. Today, clinicians provide patients classification once the course of the arrhythmia has been disclosed. This classification problem is dealt with in this study. We study a sparse representation of surface electrocardiogram signals by means of Gabor frames and afterwards we apply a linear discriminant analysis. Thus, we provide an early discrimination, obtaining promising…

AdultMalemedicine.medical_specialtyEXPRESION GRAFICA EN LA INGENIERIAmedicine.medical_treatment0206 medical engineeringBiomedical EngineeringBiophysicsCatheter ablation02 engineering and technology030204 cardiovascular system & hematologyPharmacological treatmentElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineSinus rhythmAgedAged 80 and overbusiness.industrySignal Processing Computer-AssistedAtrial fibrillationMiddle Agedmedicine.diseaseLinear discriminant analysisAtrial fibrillation020601 biomedical engineeringElectrocardiogramPersistent atrial fibrillationCohortCatheter AblationCardiologyClassification methodsFemaleGabor framesbusinessMedical Engineering &amp; Physics
researchProduct

Detection of spontaneous echocardiographic contrast within the left atrium by transesophageal echocardiography: spontaneous echocardiographic contrast

1986

Transesophageal echocardiography was performed in 314 patients over a period of 24 months using a 3.5 MHz phased-array system fitted to the distal end of a conventional 12 mm endoscope. In 12 patients (2.6%) transesophageal echocardiography could not be performed because of adverse reaction to the gastroscopic procedure. Side effects were a transient A-V block in one patient and asthmatic attack in another. Mitral valve lesions were found in 99 of 314 patients. In 9 of these 99 patients (11%), including 1 patient with mitral valve stenosis and sinus rhythm, 2 with atrial fibrillation, 3 with disc, and 3 with porcine mitral prosthesis, spontaneous echocardiographic contrast was found within …

AdultMalemedicine.medical_specialtyEndoscopeEsophagusPostoperative ComplicationsMitral valve stenosisInternal medicineMitral valveHumansMitral Valve StenosisMedicineSinus rhythmHeart AtriaEsophagusbusiness.industryMitral Valve InsufficiencyThrombosisAtrial fibrillationGeneral MedicineIntracranial Embolism and ThrombosisMiddle Agedmedicine.diseasePeripheralmedicine.anatomical_structureEmbolismEchocardiographyHeart Valve Prosthesiscardiovascular systemCardiologyFemaleRadiologyCardiology and Cardiovascular MedicinebusinessClinical Cardiology
researchProduct

Wave similarity mapping shows the spatiotemporal distribution of fibrillatory wave complexity in the human right atrium during paroxysmal and chronic…

2005

Introduction: The complexity of waveforms during atrial fibrillation may reflect critical activation patterns for the arrhythmia perpetuation. In this study, we introduce a novel concept of map, based on the analysis of the wave morphology, which gives a direct evidence in the human right atrium on the spatiotemporal distribution of fibrillatory wave complexity in paroxysmal (PAF) and chronic (CAF) atrial fibrillation. Methods and Results: Electrograms were recorded from a 64-electrode catheter in the right atrium of 15 patients during PAF (n = 8) and CAF (n = 7). Wave similarity maps were constructed by calculating the degree of morphological similarity of activation waves (S) at each atri…

AdultMalemedicine.medical_specialtyMorphological similarityPhysiologyArrhythmia (mechanisms)Heart Conduction SystemPhysiology (medical)Internal medicineAtrial FibrillationmedicineChronic atrial fibrillationHumansWaveHeart AtriaAnatomic LocationAtrium (architecture)business.industryBody Surface Potential MappingSpatiotemporal patternAtrial fibrillationMiddle Agedmedicine.diseasemedicine.anatomical_structureMappingChronic DiseaseCardiologyRight atriumFemalebusinessLateral wallSubstrateCardiology and Cardiovascular MedicineElectrophysiologic Techniques CardiacJournal of cardiovascular electrophysiology
researchProduct

Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation

2006

Aims To describe guideline adherence and application of different stroke risk stratification schemes regarding antithrombotic therapy in real-life atrial fibrillation (AF) patients and to assess which factors influence antithrombotic management decisions. Methods and results The Euro Heart Survey enrolled 5333 AF patients in 35 countries, in 2003 and 2004. Prescription of antithrombotic drugs, especially oral anticoagulation (OAC), was hardly tailored to the patient's stroke risk profile as indicated by the joint guidelines of the American College of Cardiology, American Heart Association, and the European Society of Cardiology, ACCP guidelines, or CHADS2 and Framingham risk scores. In mult…

AdultMalemedicine.medical_specialtyOral anticoagulationGuidelineRisk AssessmentElectrocardiographyFibrinolytic AgentsRisk FactorsDrug CombinationAntithromboticmedicineHumansOutpatient clinicRisk factorMultivariate AnalysiStrokeRisk stratificationAgedAntithrombotic therapyFibrinolytic AgentFramingham Risk Scorebusiness.industryRisk FactorAtrial fibrillationMiddle Agedmedicine.diseaseAtrial fibrillationStrokeDrug CombinationsMultivariate AnalysisPractice Guidelines as TopicEmergency medicinePhysical therapyFemaleGuideline AdherenceCardiology and Cardiovascular MedicinebusinessCardioversionsRisk assessmentHumanEuropean Heart Journal
researchProduct

ADMA, subclinical changes and atrial fibrillation in the general population.

2015

Abstract Background Pathways of oxidative stress, nitric oxide bioavailability and l-arginine derivatives are hypothesized to be related to atrial fibrillation (AF). Circulating methylated l-arginine metabolites can be assessed in the general population and may show an association with AF. Methods We determined l-arginine and its metabolites asymmetric dimethylarginine (ADMA), l-N ω -monomethylarginine (NMMA) and symmetric dimethylarginine (SDMA) in the population-based Gutenberg Health Study (n=5000), mean age 55±11years, 51% men, in association with clinical variables of AF such as electrocardiographic and echocardiographic measures and manifest AF. Results Individuals with AF (N=161), 71…

AdultMalemedicine.medical_specialtyPopulation030204 cardiovascular system & hematologyArginine03 medical and health scienceschemistry.chemical_compoundQRS complexElectrocardiography0302 clinical medicineTandem Mass SpectrometryInternal medicineGermanyAtrial FibrillationmedicineHumanseducationAgedCreatinineeducation.field_of_studyomega-N-Methylargininebusiness.industryAtrial fibrillationOdds ratioMiddle Agedmedicine.diseaseConfidence interval3. Good healthOxidative StressEndocrinologychemistryEchocardiographyPopulation SurveillanceCardiologyOmega-N-MethylarginineFemaleMorbidityCardiology and Cardiovascular MedicineAsymmetric dimethylargininebusiness030217 neurology & neurosurgeryBiomarkersChromatography LiquidInternational journal of cardiology
researchProduct